Opko Health Inc. buy melinda
Start price
27.11.17
/
50%
€4.20
Target price
28.05.18
€6.00
Performance (%)
-23.50%
End price
28.05.18
€3.21
Summary
This prediction ended on 28.05.18 with a price of €3.21. The price of Opko Health Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.50%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Opko Health Inc. | 3.518% | 3.518% | -13.387% | -14.735% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % | 50,71 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % | 102,82 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % | 64,80 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % | 70,25 % |
Comments by melinda for this prediction
In the thread Opko Health Inc. diskutieren
Pharmazeutische SecteurProduits Agenda 28/02 Ergebnisse Veröffentlichung
OPKO Health, Inc.
OPKO Health registriert seinen ersten Patienten in der Phase 2B von OPK88004 gutartiger Prostatahypertrophie zu behandeln
(Laufzeit überschritten)